Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI), A Randomized, Double Blind, Placebo Controlled Clinical Trial (P-CRESCENT)

NCT04322669 is registered in ClinicalTrials.gov with Almirall, S.A. as lead sponsor.

NCT NCT04322669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04322669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI), A Randomized, Double Blind, Placebo Controlled Clinical Trial (P-CRESCENT)
Lead sponsor
Almirall, S.A.
Phase
Phase 4
Overall status
Completed
Start date
August 4, 2021
Completion date
November 4, 2021
Enrollment
338 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent respiratory tract infections